Achieving sustained outcomes for moderate-to-severe atopic dermatitis

touchTALKS for touchIMMUNOLOGY This touchPODCAST is presented by Dr Melinda Gooderham, SKiN Centre for Dermatology, Peterborough, Ontario, Canada. Listen to Dr Gooderham present the latest data and future directions of systemic therapy for moderate-to-severe atopic dermatitis and how effective treatment can achieve sustained control of symptoms and improve the quality of life of patients and their families. This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME. For further information visit our website:  https://touchimmunologyime.org/systemic-therapy-atopic-dermatitis